- Home
- ADC vs BRKR Comparison
ADC vs BRKR Comparison
Compare ADC & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADC | BRKR |
|---|---|---|
| Founded | 1971 | 1960 |
| Country | United States | United States |
| Employees | 90 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 9.0B |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | ADC | BRKR |
|---|---|---|
| Price | $76.09 | $52.61 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | ★ $84.50 | $48.54 |
| AVG Volume (30 Days) | 1.1M | ★ 2.2M |
| Earning Date | 04-21-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.12% | 0.58% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $1,895,600,000.00 |
| Revenue This Year | $12.01 | $6.30 |
| Revenue Next Year | $9.90 | $3.81 |
| P/E Ratio | ★ $43.33 | $2,515.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $69.56 | $28.53 |
| 52 Week High | $82.08 | $65.30 |
Technical Indicators
Market Signals| Indicator | ADC | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 37.62 | 39.80 |
| Support Level | $75.38 | $44.85 |
| Resistance Level | $76.38 | $64.18 |
| Average True Range (ATR) | 1.38 | 3.85 |
| MACD | -0.66 | -1.13 |
| Stochastic Oscillator | 4.47 | 19.11 |
Price Performance
Historical ComparisonAbout ADC Agree Realty Corporation
Agree Realty Corporation operates as a fully integrated real estate investment trust mainly focused on the ownership, acquisition, development and management of retail properties net leased to industry-tenants. The Company is mainly in the business of acquiring, developing and managing retail real estate. Some of its properties in the portfolio include Walmart, 7-Eleven, Wawa, Gerber Collision and others.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.